Santa Ana, California
Velocity Clinical Research, Santa Ana
Velocity's Santa Ana research site was founded as the National Research Institute, a five-site research network in southern California, and acquired by Velocity in 2021. Our Santa Ana site offers a wide range of expertise including diabetes, NASH, vaccines, psychiatry, women’s health, and pediatric trials. Santa Ana’s experienced staff maintains high quality standards and enrollment on all their trials.
Located outside of Los Angeles, the Santa Ana site is easily accessible for patients through public transport. The Santa Ana team is bilingual, allowing the site to recruit diverse patient populations. The local hospital is located next door to the site.
All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Santa Ana team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.
Velocity Clinical Research, Santa Ana
2621 South Bristol Street #303, Santa Ana, CA 92704
Phone: (714) 599-8711
Find a Clinical Trial in Santa Ana
Sign up below to speak with an enrollment specialist about available research studies in Santa Ana.
Follow Velocity on Facebook for company updates and more.
Our experienced research team in Santa Ana
Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Santa Ana is dedicated to conducting quality research in a professional and caring environment.
Mark Leibowitz, MD is an experienced and skilled Investigator with approximately 25 years of research experience. Dr. Leibowitz has participated in an estimated 500 studies from Phase I-IV across a variety of different indications. As part of his research portfolio, Dr. Leibowitz has conducted highly complex studies in healthy subjects and diverse patient populations including continuous cerebrospinal fluid studies, First in Human, Single and Multiple Ascending Dose studies, Ethnic bridging programs, QTc studies, as well as, serving as Principal Investigator for many adaptive trial designs. His experience includes leadership roles such as Medical Director for research sites located in California and Texas. In addition, he is currently a contributing member for a Data Safety Monitoring Board.
Tshekedi Dennis, MD is a board-certified Psychiatrist who has over 10 years of research experience as an Investigator and over 20 years in clinical medicine. He has conducted dozens of studies in indications such as Depressive Disorders, Post-Traumatic Stress Disorder (PTSD), General Anxiety, Schizophrenia, Dementia, Addiction, and more. Dr. Dennis has received recognition as a Fellow of the American Psychiatric Association and as a past recipient of the Faculty of the Year award from the UCLA-Kern Medical Center. In the Southern California community, Dr. Dennis is an Assistant Clinical Professor of Psychiatry & Neuroscience at UCR SOM (University of California Riverside School of Medicine). He continues to be active with patient care as well as psychiatry education and training.
Stanley Hsia, MD is an Associate Professor of Medicine at Charles R. Drew University of Medicine and Science, and a Health Sciences Associate Clinical Professor with the David Geffen School of Medicine at UCLA. He is board certified in Internal Medicine as well as Endocrinology and Metabolism, and is a consultant endocrinologist for the Diabetes Clinic at the Martin Luther King Jr. Multi-Service Ambulatory Care Center. He has also served as a program director for residents and endocrinology fellows, and as a clerkship director for the Drew/UCLA medical students. Dr. Hsia has been conducting clinical research over the past 13 years, including both industry and investigator-initiated trials, and has been funded by grants from National Institutes of Health and the American Diabetes Association. He has also published original research, book chapters, review papers and CME programs on the management of lipid disorders, insulin resistance, and diabetes mellitus.
John Nelson, PA-C is a skilled Physician Assistant with over 20 years of medical and clinical research experience in a variety of indications such as Pulmonary Medicine and Critical Care, Internal Medicine, Gastroenterology, Infectious Disease, Emergency Medicine, and Geriatrics. He obtained his Physician Assistant certification from the USC School of Medicine. John currently serves as a Sub-Investigator for multiple Velocity sites in the LA area and is a member of the California Academy of Physician Assistants.
Minie Mercado, LVN, is a highly seasoned research professional. She has conducted studies from Phase 1-4 for the past 25 years. Some of her experience includes CNS, Metabolic, and Liver Disease. Prior to Velocity, she was head of NASH Research with a local Hepatology center.
Complete the form to start your clinical trial journey in Santa Ana
Beyond helping advance medicine, you may also:
- Get care from a local doctor at no cost
- Learn about new medicines in development
- Receive study-related medical exams at no cost
- Get paid for participating (amounts differ for each study)
After you submit your info, a Velocity staff member will review your info. They will contact you to talk about the study, or others that may be right for you.
Health insurance is generally not needed to join a clinical trial.
Remember, there is never an obligation to join — we're here to help you make the best decision.
Submit your info
Sponsors and CROs
From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.